Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous puncture, hemodialysis online dry powder bags/cylinders, disinfectants, hemodialysis concentrates, and medical adsorbable suture with needles. The company offers its products in Germany, Italy, Turkey, Thailand, Vietnam, the Philippines, South Africa, Kenya, Chile, Peru, and the United Arab Emirates. Jafron Biomedical Co.,Ltd. was founded in 1989 and is based in Zhuhai, China.

Jafron Biomedical Co.,Ltd.

山东前沿医疗器械股份有限公司 manufactures medical ozone therapy devices and other medical equipment, self-described as a high-tech enterprise.

山东前沿医疗器械股份有限公司

健帆生物科技集团股份有限公司, established in 1989, specializes in the research, production, and sales of biological materials and high-tech medical devices. It focuses on blood purification products and is listed on the A-share Growth Enterprise Market.

Metric
Company Name	Jafron Biomedical Co.,Ltd.	山东前沿医疗器械股份有限公司
Symbol	300.53K
MSH ID	COM:JAFRON	CN:COM:ZAMT
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Devices	Medical Devices
Country	CN	CN
Stage
Employee Count	2.41K
Website	jafron.com	zamt.com.cn
LinkedIn
Founders

Metric
Market Cap	3.09B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	264.41M
Revenue (LTM)
Revenue (NTM)
Gross Profit	211.60M
EBITDA	94.00M
Operating Income	74.80M
Net Income	60.04M
EPS	0.08
Diluted EPS	0.08
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.80
Operating Profit Margin	0.35
EBITDA Margin	0.36
Net Profit Margin	0.30
Return on Equity	0.23
Return on Assets	0.13
Return on Capital Employed	0.19

3005

COM:JAFRON

健帆生物科技集团股份有限公司

Last Close

26.16

14/02 07:04

Market Cap

22.44B

Beta: -

Volume Today

8.75M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	30.96
P/B Ratio	4.34
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	11.71
EV Multiple	35.33

Metric
Days Sales Outstanding	49.25
Days Payables Outstanding	130.32
Days Inventory Outstanding	330.65
Operating Cycle	379.90
Cash Conversion Cycle	249.58
Asset Turnover	0.44

Metric
Operating Cash Flow	126.09M
Free Cash Flow	92.09M
Cash Flow to Debt	0.68
Operating Cash Flow/Sales	0.57
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents	386.54M
Accounts Receivable
Inventory	52.95M
Goodwill	1.68M
Debt to Capitalization	0.37
Debt to Assets	0.32
Current Ratio	4.07
Quick Ratio	3.54

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.14
SG&A to Revenue	0.03